Development of a phenotypic screening platform for drug repositioning, discovery of new chemical entities and validation of targets for treatment of COVID-19
- Funded by University of São Paulo
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
University of São PauloPrincipal Investigator
Unspecified Unspecified UnspecifiedResearch Location
BrazilLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
This initiative consists of using human cell cultures infected with the SARS-CoV-2 coronavirus and evaluating the antiviral activity of different molecules, both synthetic and natural. This initiative is developed in the biosafety level 3 laboratory (NB3) of the Microbiology Department at ICB-USP.